Grown Rogue International (GRUSF) Free Cash Flow Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -351.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -351.85% |
| Mar 31, 2026 | 102.57% |
| Dec 31, 2025 | -85,066,906.27% |
| Sep 30, 2025 | 86,248,785.29% |
| Jun 30, 2025 | -65.53% |
| Mar 31, 2025 | -166.96% |
| Jan 31, 2023 | 6.86% |
| Jan 31, 2022 | 1,882.31% |
| Oct 31, 2021 | 124,440,112.34% |
| Jul 31, 2021 | -42,561,186.85% |
| Apr 30, 2021 | -591.40% |
| Jan 31, 2021 | -124.42% |
| Oct 31, 2020 | 32.58% |
| Jul 31, 2020 | 60.07% |
| Apr 30, 2020 | -492.70% |
| Jan 31, 2020 | 106.98% |
| Oct 31, 2019 | 66.31% |
| Jul 31, 2019 | -47.34% |
| Apr 30, 2019 | 106.91% |
| Jan 31, 2019 | -938.47% |